Cerebral Amyloid and Hypertension are Independently Associated with White Matter Lesions in Elderly
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
In cognitively normal (CN) elderly individuals, white matter hyperintensities (WMH) are commonly viewed as a marker of cerebral small vessel disease (SVD). SVD is due to exposure to systemic vascular injury processes associated with highly prevalent vascular risk factors (VRFs) such as hypertension, high cholesterol, and diabetes. However, cerebral amyloid accumulation is also prevalent in this population and is associated with WMH accrual. Therefore, we examined the independent associations of amyloid burden and VRFs with WMH burden in CN elderly individuals with low to moderate vascular risk. Participants (n = 150) in the Alzheimer's Disease Neuroimaging Initiative (ADNI) received fluid attenuated inversion recovery (FLAIR) MRI at study entry. Total WMH volume was calculated from FLAIR images co-registered with structural MRI. Amyloid burden was determined by cerebrospinal fluid Aβ1-42 levels. Clinical histories of VRFs, as well as current measurements of vascular status, were recorded during a baseline clinical evaluation. We tested ridge regression models for independent associations and interactions of elevated blood pressure (BP) and amyloid to total WMH volume. We found that greater amyloid burden and a clinical history of hypertension were independently associated with greater WMH volume. In addition, elevated BP modified the association between amyloid and WMH, such that those with either current or past evidence of elevated BP had greater WMH volumes at a given burden of amyloid. These findings are consistent with the hypothesis that cerebral amyloid accumulation and VRFs are independently associated with clinically latent white matter damage represented by WMHs. The potential contribution of amyloid to WMHs should be further explored, even among elderly individuals without cognitive impairment and with limited VRF exposure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study
D’Agostino, R. B., Vasan, R. S., Pencina, M. J., Wolf, P. A., Cobain, M., Massaro, J. M., & Kannel, W. B. (2008) · Circulation · doi:10.1161/circulationaha.107.699579 · Cited by 7,491 · cited 1×
“Second, because amyloid measurement (via CSF) was optional in ADNI1, the proportion of individuals in ADNI-1 with both WMH and amyloid measurements is far smaller than in ADNI-2.”
BackgroundThe Alzheimer’s disease neuroimaging initiative (ADNI): MRI methods
Jack, C. R., Bernstein, M. A., Fox, N. C., Thompson, P., Alexander, G., Harvey, D., Borowski, B., Britson, P. J., L. Whitwell, J., Ward, C., et al. (2008) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.21049 · Cited by 4,347
Baumgart, M., Snyder, H. M., Carrillo, M. C., Fazio, S., Kim, H., & Johns, H. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2015.05.016 · Cited by 1,660 · cited 5×
“…Thompson2, Michael Weiner3, Charles DeCarli1, Owen T. Carmichael4 and the Alzheimer’s Disease Neuroimaging Initiative† 1 IDeA Laboratory, Department of Neurology, University of California, Davis, Davis, CA, USA, 2 Imaging Genetics Center, Keck School of Medicine, University of Southern California,…”
BackgroundMethodInfluentialPike, K. E., Savage, G., Villemagne, V. L., Ng, S., Moss, S. A., Maruff, P., Mathis, C. A., Klunk, W. E., Masters, C. L., & Rowe, C. C. (2007) · Brain · doi:10.1093/brain/awm238 · Cited by 789 · cited 1×
“…studies of the association between systemic vascular injury and WMHs largely did not measure cerebral amyloid, which is known to be highly prevalent among elderly individuals, including those lacking clinically significant cognitive impairment (Price and Morris, 1999; Pike et al., 2007).”
BackgroundHeterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations
Gouw, A. A., Seewann, A., van der Flier, W. M., Barkhof, F., Rozemuller, A. M., Scheltens, P., & Geurts, J. J. G. (2011) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2009.204685 · Cited by 766
β-Amyloid-mediated vasoactivity and vascular endothelial damage
Thomas, T., Thomas, G., McLendon, C., Sutton, T., & Mullan, M. (1996) · Nature · doi:10.1038/380168a0 · Cited by 703 · cited 1×
“…confirmed, this finding supports a mechanism in which long-term exposure to elevated BP and other vascular risks weakens the integrity of the cerebral vasculature, leaving it less well equipped to facilitate the clearance of amyloid as its production accelerates later in life (Thomas et al., 1996).”
ResultVascular contributions to cognitive impairment and dementia including Alzheimer's disease
Snyder, H. M., Corriveau, R. A., Craft, S., Faber, J. E., Greenberg, S. M., Knopman, D., Lamb, B. T., Montine, T. J., Nedergaard, M., Schaffer, C. B., et al. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.10.008 · Cited by 603 · cited 3×
“…CAA) could exacerbate cerebrovascular injury processes that contribute to WMHs; cerebrovascular dysfunction associated with systemic vascular injury could conversely exacerbate amyloid accrual by disrupting amyloid clearance via perivascular spaces (Preston et al., 2003; Snyder et al., 2015).”
BackgroundDufouil, C., Chalmers, J., Coskun, O., Besançon, V., Bousser, M.-G., Guillon, P., MacMahon, S., Mazoyer, B., Neal, B., Woodward, M., et al. (2005) · Circulation · doi:10.1161/circulationaha.104.501163 · Cited by 461 · cited 2×
“History of hypertension was associated with greater WMH volume in our study, in agreement with findings from large epidemiological samples (Dufouil et al., 2005; Allan et al., 2014; Rosano et al., 2014).”
ResultExtent and distribution of white matter hyperintensities in normal aging, MCI, and AD
Yoshita, M., Fletcher, E., Harvey, D., Ortega, M., Martinez, O., Mungas, D. M., Reed, B. R., & DeCarli, C. S. (2006) · Neurology · doi:10.1212/01.wnl.0000249119.95747.1f · Cited by 434 · cited 3×
“…by: P. Hemachandra Reddy, Texas Tech University, USA Reviewed by: Anna Maria Colangelo, University of Milano-Bicocca, Italy Ramesh Kandimalla, Emory University, USA *Correspondence: Julia A. Scott jascott@ucdavis.edu †Data used in the preparation of this article were obtained through…”
BackgroundMethodInfluentialSelf-citationCerebral white matter lesions and atherosclerosis in the Rotterdam Study
Bots, M. L., Breteler, M. M. B., Hofman, A., Grobbee, D. E., van Swieten, J. C., van Gijn, J., van Swieten, J. C., & de Jong, P. T. V. M. (1993) · The Lancet · doi:10.1016/0140-6736(93)91144-b · Cited by 361
Cited by
White matter changes in Alzheimer’s disease: A focus on myelin and oligodendrocytes
Nasrabady, S. E., Rizvi, B., Goldman, J. E., & Brickman, A. M. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0515-3 · Cited by 723
“White matter hyperintensity severity is associated with cerebrospinal fluid (CSF) amyloid levels independent of vascular risk factors [71].”
Weiner, M. W., Veitch, D. P., Aisen, P. S., Beckett, L. A., Cairns, N. J., Green, R. C., Harvey, D., Jack, C. R., Jagust, W., Morris, J. C., et al. (2017) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.11.007 · Cited by 315
Self-citationDadar, M., Camicioli, R., Duchesne, S., Collins, D. L., & Initiative, F. T. A. D. N. (2020) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1002/dad2.12091 · Cited by 64
White matter hyperintensities are associated with subthreshold amyloid accumulation
Moscoso, A., Rey-Bretal, D., Silva-Rodríguez, J., Aldrey, J. M., Cortés, J., Pías-Peleteiro, J., Ruibal, Á., & Aguiar, P. (2020) · NeuroImage · doi:10.1016/j.neuroimage.2020.116944 · Cited by 49
Association of vascular brain injury, neurodegeneration, amyloid, and cognitive trajectory
Han, J. W., Maillard, P., Harvey, D., Fletcher, E., Martinez, O., Johnson, D. K., Olichney, J. M., Farias, S. T., Villeneuve, S., Jagust, W., et al. (2020) · Neurology · doi:10.1212/wnl.0000000000010531 · Cited by 49
Self-citation
Metadata
- Authors
- Scott, J. A., Braskie, M. N., Tosun, D., Thompson, P. M., Weiner, M., DeCarli, C., & Carmichael, O. T.
- Venue
- Frontiers in Aging Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2015-12-01
- Volume
- 7
- Pages
- 221-221
- ISSN
- 1663-4365 (ISSN-L)
- OpenAlex
- W2190323360
- Cited by
- 59
- References
- 16
- FWCI
- 4.05
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cerebral Amyloid and Hypertension are Independently Associated with White Matter Lesions in Elderly. https://app.cochat.ai/papers/10.3389/fnagi.2015.00221
- The paper
- Scott, J. A., Braskie, M. N., Tosun, D., Thompson, P. M., Weiner, M., DeCarli, C., & Carmichael, O. T. (2015). Cerebral Amyloid and Hypertension are Independently Associated with White Matter Lesions in Elderly. Frontiers in Aging Neuroscience. https://doi.org/10.3389/fnagi.2015.00221
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.